ZhongqiuJohnZhangMDPhD. FACS, FASCRS

Zhongqiu John Zhang MD, PhD, FACS. FASCRS. General and Colorectal Surgeon Department of Surgery Waterbury Hospital Health Center Associate Professor of Surgery Frank H Netter School of Medicine at Quinnipiac University Clinical Assistant Professor of Surgery University of Connecticut School of Medicine

Join to view full profile

Dr. Zhang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zhang's full profile

Already have an account?

Office
Waterbury Hospital
64 Robbins street
Waterbury, CT 06708
Phone+1 203-573-7257

Fax+1 203-573-6073

Education & Training

Cleveland Clinic FoundationResidency, Colon and Rectal Surgery, 2009 - 2010
Quinnipiac University Frank H Netter MD School of Medicine (Waterbury Hospital)Residency, Surgery, 2004 - 2009
Capital University of Medical SciencesClass of 1989

Certifications & Licensure

CT State Medical License 2009 - 2025
OH State Medical License 2009 - 2010
American Board of Colon and Rectal Surgery Colon & Rectal Surgery
American Board of Surgery Surgery

Awards, Honors, & Recognition

FASCRS American Society of Colon and Rectal Surgeons
Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

55 citations
Molecular Alterations and Lung Tumors in p53 Mutant Mice Exposed to Cigarette Smoke
Silvio De Flora, Roumen Balansky, Francesco D'Agostini, Alberto Izzotti, Anna Camoirano
Cancer Research. 2003-02-15
29 citations
Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf.
Zhongqiu Zhang, Yian Wang, Laura E. Lantry, Elizabeth Kastens, Gongjie Liu
Oncogene. 2003-09-18
42 citations
LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer.
Jie Li, Zhongqiu Zhang, Zunyan Dai, Christoph Plass, Carl Morrison
Oncogene. 2003-02-27

Journal Articles

Wildtype Kras2 can inhibit lung carcinogenesis in mice
Z Zhang 1, Y Wang, H G Vikis, L Johnson, G Liu, J Li, M W Anderson, R C Sills, H L Hong, T R Devereux, T Jacks, K L Guan, M You, Nat. Genet, 9/29/2001